CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Opthea Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 15, 2025
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2018 to 2025
Operating margin
-623048.0%
Net margin
-651164.0%−632330.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -80.0% | -34.9% | -15.8% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | – | -29.3% | -132.6% | |
| Current ratio | – | 10.31 | 0.22 | |
| Interest coverage | – | – | -19470.3× | |
| Capex to revenue | – | 4.3% | 52.0% | |
| Diluted shares | – | 261M | 1.22B |
Where the cash went
Fiscal 2021 to 2025, five years combined
Opthea generated $557.15M from operations and spent $97.61K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$557.15M
Used
$97.61K
Capital expenditure$97.61K100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
2of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$162.79M
- Cash generatingOperating cash flow above zero-$158.64M
- Return on assets improvedROA up on the prior year-223.3% → -86.2%
- Earnings backed by cashOperating cash flow above net income-$158.64M vs -$162.79M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.94 → 0.22
- No dilutionShare count did not rise638M → 1.22B
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.00 → 0.00